Our Solutions & Activities
Our Solutions & Activities are addressing directly or indirectly several Sustainable Development Goals across all institutes.
Bacterial Ecophysiology and Biotechnology, DTU-Bioengineering: We increase scientific knowledge about the use of probiotics instead of antibiotics, developing research capacity and transfer of marine technology (target 14.a).
Synthetic Biology Tools for Yeast, DTU-Biosustain: Target 14.7 on sustainable management of aquacultures is addressed in our EU project "COMBO". We support accurate co-cultivations with marine organisms and yeast and bacteria aiming at marine production.
Sustainable Food Innovation, DTU-Biosustain: We work towards optimisation of our water resources by water through the use of more traditional fermentation processes and culinary techniques (target 6.4).
Bacterial Ecophysiology and Biotechnology, DTU-Bioengineering: We work towards protection and restoration of our water resources by limiting antibiotic effluent through the use of probiotics in aquaculture (target 6.6).
Sustainable Food Innovation, DTU-Biosustain: We work towards gender equality by making it a conscious criteria when hiring, as well as making space for non-binary and genderqueer folks.
Bacterial Ecophysiology and Biotechnology, DTU-Bioengineering: We actively ensure a 1:1 male to female ration within our laboratory at all carrier stages.
Synthetic Biology Tools for Yeast, DTU-Biosustain: We actively ensure a 1:1 male to female ration within our laboratory.
Gut, Microbes and Health, DTU-FOOD: We work towards prevention and treatment of non-communicable diseases in order to reduce premature mortality from them by targeting the microbiota to prevent, reduce toxic effects of, and alleviate inflammatory and metabolic diseases (target 3.4). We further identify microorganisms than can target the virulence of pathogenic streptococci (target 3.b).
Bacterial Ecophysiology and Biotechnology, DTU-bioengineering: Through the work performed at the Center for microbial secondary metabolites we aim to discover new antibiotics (target 3.d).